SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
Guardado en:
Autores principales: | Natalia Vargas-Herrera, Roger V Araujo-Castillo, Orson Mestanza, Marco Galarza, Nancy Rojas-Serrano, Lely Solari-Zerpa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff56cc40b1e44dc7b0819c2acc01b86a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
por: Dianna L. Ng, et al.
Publicado: (2020) -
SARS CoV-2 seroprevalence in a US school district during COVID-19
por: Benjamin Lee, et al.
Publicado: (2021) -
Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil
por: Stephanie L.S. Penetra, et al.
Publicado: (2022) -
Large-Scale Screening of Asymptomatic Persons for SARS-CoV-2 Variants of Concern and Gamma Takeover, Brazil
por: Douglas Adamoski, et al.
Publicado: (2021) -
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Ann-Sofie Rudberg, et al.
Publicado: (2020)